biostudies-literatureUnknown392(10143)Barouch DHNCATS NIH HHSJanssen Vaccines & Prevention BVNIAID NIH HHSRagon Institute of MGH, MIT and HarvardNational Institutes of HealthNIH HHSthe Bill & Melinda Gates FoundationJanssen PharmaceuticalsLancet (London, England)232-243https://www.ebi.ac.uk/biostudies/studies/S-EPMC6192527biostudies-literatureEvaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).PMC6192527AI124377UM1 AI069469R01 OD024917UM1 AI124377OD024917TR001102UL1 TR001102AI126603U19 AI096040UM1 AI068618AI078526AI128751U19 AI128751U19 AI078526U01 AI068618W81XWH-07-2-0067K23 AI114381AI068618UM1 AI069453AI096040UM1 AI126603Feddes-de Boer KSwann ENijs Svan Manen DTolboom JSchuitemaker HEuler ZHutter JKibuuka HMcElrath MJLucksinger GBorducchi ENPau MGWeijtens MLavreys LMpendo JJetton DKorber BLi WWegmann FGarrett NChinyenze KBorremans CMngadi KChandrashekar AVreugdenhil JJohnson JKarita EPeter LHendriks JSadoff JLaher FAlter GNitayapan SScheppler LFeldman RPitisuttithum PStieh DJMontefiori DCZahn RCampbell TBarouch DHCallewaert KLazarus EBaden LRoten RFrahm NTomaka FLGray GRobb MLBart SPriddy FNkolola JPMichael NLTomaras GDStephenson KEfalseEvaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).2018-01-01T00:00:00Z2018 Jul2026-05-01T19:54:47.403Z2025-04-04T11:21:11.429ZS-EPMC61925273004737610.1016/s0140-6736(18)31364-310.1016/S0140-6736(18)31364-3